Glympse Bio, Inc. logo

Glympse Bio, Inc.

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platform technology was originally developed at MIT, and is founded by a team of world renowned experts in nanomedicine and biomedical engineering.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.glympsebio.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
700 Main Street, MA 02139
Cambridge
United States
Email
Contact Number
+1 617-863-3636

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/glympse-bio” connections=”true” suffix=””]